1350 Avenue Of The Americas, Suite 2405, New York, NY 10019-4801
Investment Services & Portfolio Management
Casdin Capital focuses on investments in disruptive businesses and is positioned to capitalize off an underappreciated, disruptive technology shift currently unfolding in the life sciences and healthcare industry. They consider investment opportunities that span the entire healthcare continuum and into sectors such as agriculture, industrial manufacturing and traditional information technology.
Ernst & Young LLP engages in the provision of assurance, tax, transactions, and advisory services. It offers audit, business risk, technology, security risk, and human capital services. The company was founded by Arthur Young and Alwin C. Ernst in 1989 and is headquartered in New York, NY.
908 Devices, Inc. develops devices for chemical analysis. It develops its products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. The firm offers battery-operated, handheld, and chemical detection tools; and personal analyzers for biologists and chemists. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andy Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.
Syros Pharmaceuticals, Inc. engages in the development of novel gene control therapies for cancer and other diseases. It has developed a proprietary platform that is designed to systematically and efficiently analyze unexploited region of DNA in human disease tissue to identify and drug novel targets linked to genomically defined patient populations. The company focuses on developing treatments for cancer and immune mediated diseases and is building a pipeline of gene control medicines. Syros Pharmaceuticals was founded by Richard A. Young, Nathanael S. Gray and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Flatiron Health, Inc. develops health care technology. Its OncologyCloud platform allows cancer centers, physicians and life science companies to gain actionable insights from clinical, practice management and billing data. The firm's software platform accelerates personalized medicine and research by applying advanced analytics to electronic patient care data documented by physicians. The company was founded by Nathaniel S. Turner and Zachary W. Weinberg in 2012 and is headquartered in New York, NY.
Gritstone Oncology, Inc. provides cancer immunotherapy therapeutics services. The company was founded by Andrew Allen, Tim Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria and is headquartered in Emeryville, CA.